218 related articles for article (PubMed ID: 1359788)
81. Preparation and characterization of a monoclonal antibody against bovine T cell surface antigen associated with the bovine homologue of CD2.
Koyama H; Tsunemi E; Hohdatsu T
J Vet Med Sci; 1991 Feb; 53(1):153-7. PubMed ID: 1677817
[No Abstract] [Full Text] [Related]
82. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human antimouse responses.
Hafler DA; Weiner HL
Ann N Y Acad Sci; 1988; 540():557-9. PubMed ID: 2905125
[No Abstract] [Full Text] [Related]
83. Prevention of spontaneous but not of adoptively transferred diabetes by injection of neonatal BB/hooded hybrid rats with splenocytes or concanavalin A blasts from diabetes-free strains.
Logothetopoulos J; Shumak K; Bailey D
Diabetes; 1988 Aug; 37(8):1009-14. PubMed ID: 3391342
[TBL] [Abstract][Full Text] [Related]
84. Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.
Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Rosenthal H; Westermann J
Ann Rheum Dis; 1997 Dec; 56(12):716-22. PubMed ID: 9496150
[TBL] [Abstract][Full Text] [Related]
85. Quantitative phenotypic and functional analyses of islet immune cells before and after diabetes onset in the BB rat.
Hosszufalusi N; Chan E; Teruya M; Takei S; Granger G; Charles MA
Diabetologia; 1993 Nov; 36(11):1146-54. PubMed ID: 8270129
[TBL] [Abstract][Full Text] [Related]
86. Thyroglobulin-reactive T lymphocytes in thyroiditis-prone BB/Wor rats.
Allen EM; Thupari JN
J Endocrinol Invest; 1995 Jan; 18(1):45-9. PubMed ID: 7759784
[TBL] [Abstract][Full Text] [Related]
87. T cell depletion of bone marrow for clinical marrow allografting: optimalization of conditions for depletion by anti-CD2 and anti-CD8 monoclonal antibodies with rabbit complement, and for detection of residual T cell content.
Cooley MA; Farrelly H; O'Flaherty E; Biggs JC; Atkinson K
Pathology; 1987 Apr; 19(2):131-6. PubMed ID: 2899866
[TBL] [Abstract][Full Text] [Related]
88. Induction of unresponsiveness to Heymann's nephritis: inhibited by monoclonal antibody to CD4 but not to CD8.
Quiza CG; Leenaerts PL; Hall BM
Cell Immunol; 1991 Apr; 133(2):456-67. PubMed ID: 1901770
[TBL] [Abstract][Full Text] [Related]
89. The BB rat as a model of human insulin-dependent diabetes mellitus.
Whalen BJ; Mordes JP; Rossini AA
Curr Protoc Immunol; 2001 May; Chapter 15():15.3.1-15.3.15. PubMed ID: 18432735
[TBL] [Abstract][Full Text] [Related]
90. Role of host immune system in BB/Wor rat. Predisposition to diabetes resides in bone marrow.
Nakano K; Mordes JP; Handler ES; Greiner DL; Rossini AA
Diabetes; 1988 May; 37(5):520-5. PubMed ID: 3282942
[TBL] [Abstract][Full Text] [Related]
91. Immunopathology of diabetes in the RT6-depleted diabetes-resistant BB/Wor rat.
Jiang Z; Handler ES; Rossini AA; Woda BA
Am J Pathol; 1990 Oct; 137(4):767-77. PubMed ID: 2221011
[TBL] [Abstract][Full Text] [Related]
92. Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes.
Lefkowith J; Schreiner G; Cormier J; Handler ES; Driscoll HK; Greiner D; Mordes JP; Rossini AA
J Exp Med; 1990 Mar; 171(3):729-43. PubMed ID: 2307932
[TBL] [Abstract][Full Text] [Related]
93. Prevention of adoptive transfer in BB rats by prophylactic insulin treatment.
Bertrand S; De Paepe M; Vigeant C; Yale JF
Diabetes; 1992 Oct; 41(10):1273-7. PubMed ID: 1397700
[TBL] [Abstract][Full Text] [Related]
94. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells.
Like AA; Biron CA; Weringer EJ; Byman K; Sroczynski E; Guberski DL
J Exp Med; 1986 Oct; 164(4):1145-59. PubMed ID: 3531381
[TBL] [Abstract][Full Text] [Related]
95. Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibody.
Dehoux JP; Talpe S; Dewolf N; Otsuka M; Oike F; Jamar F; de la Parra B; Latinne D; Bazin H; Gianello P
Transplantation; 2000 Jun; 69(12):2622-33. PubMed ID: 10910286
[TBL] [Abstract][Full Text] [Related]
96. Thymic epithelial defects and predisposition to autoimmune disease in BB rats.
Doukas J; Mordes JP; Swymer C; Niedzwiecki D; Mason R; Rozing J; Rossini AA; Greiner DL
Am J Pathol; 1994 Dec; 145(6):1517-25. PubMed ID: 7992854
[TBL] [Abstract][Full Text] [Related]
97. Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat.
Mordes JP; Gallina DL; Handler ES; Greiner DL; Nakamura N; Pelletier A; Rossini AA
Diabetologia; 1987 Jan; 30(1):22-6. PubMed ID: 2952538
[TBL] [Abstract][Full Text] [Related]
98. Genetic studies in inbred BB/Wor rats. Analysis of progeny produced by crossing lymphopenic diabetes-prone rats with nonlymphopenic diabetic rats.
Guberski DL; Butler L; Kastern W; Like AA
Diabetes; 1989 Jul; 38(7):887-93. PubMed ID: 2567683
[TBL] [Abstract][Full Text] [Related]
99. Polygenic nature of spontaneous diabetes in the rat. Permissive MHC haplotype and presence of the lymphopenic trait of the BB rat are not sufficient to produce susceptibility.
Colle E; Fuks A; Poussier P; Edouard P; Guttmann RD
Diabetes; 1992 Dec; 41(12):1617-23. PubMed ID: 1446803
[TBL] [Abstract][Full Text] [Related]
100. The effect of methimazole, iodine and splenocytes on thyroid transplants in BB/Wor rats.
Allen EM; Bartlett ST
Transplantation; 1999 Jul; 68(1):25-30. PubMed ID: 10428262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
